Cargando…
In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response
A20 is an ubiquitin-editing enzyme that ensures the transient nature of inflammatory signaling pathways induced by cytokines like TNF-α and IL-1 or pathogens via Toll-like receptor (TLR) pathways. It has been identified as a negative regulator of dendritic cell (DC) maturation and attenuator of thei...
Autores principales: | Braun, Floriane C. M., van den Brandt, Jens, Thomas, Sören, Lange, Sandra, Schrank, Juliane, Gand, Claudia, Przybylski, Grzegorz K., Schmoeckel, Katrin, Bröker, Barbara M., Schmidt, Christian A., Grabarczyk, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556692/ https://www.ncbi.nlm.nih.gov/pubmed/26327508 http://dx.doi.org/10.1371/journal.pone.0135444 |
Ejemplares similares
-
TLR agonist–Stat3 siRNA conjugates: cell-specific gene silencing and enhanced antitumor immune responses
por: Kortylewski, Marcin, et al.
Publicado: (2009) -
Gene expression profiles in BCL11B-siRNA treated malignant T cells
por: Huang, Xin, et al.
Publicado: (2011) -
Silencing SOCS1 via Liposome-Packed siRNA Sustains TLR4-Ligand Adjuvant
por: Hildebrand, Dagmar, et al.
Publicado: (2019) -
Therapeutic siRNA silencing in inflammatory monocytes
por: Leuschner, Florian, et al.
Publicado: (2011) -
Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022)